Filing Analysis
eHealth, Inc. filed an 8-K to announce its financial results for the second quarter and first half of fiscal year 2026. The filing serves as a formal announcement of quarterly earnings and supplemental investor materials.
📋 Key Facts
- Company announced financial results for the three and six months ended June 30, 2026.
- The report was filed on August 4, 2026.
- Supplemental investor material was posted to the company's investor relations webpage.
- Exhibits include a press release (99.1) and conference call slides (99.2).
eHealth, Inc. held its 2026 Annual Meeting of Stockholders on June 18, 2026, reporting the results of stockholder votes. Key outcomes included the election of two directors and approval of an amendment to the company's equity incentive plan.
📋 Key Facts
- Annual Meeting held on June 18, 2026.
- Stockholders approved an amendment to the 2024 Amended Equity Plan to increase the maximum number of shares by 1,300,000.
- Prama Bhatt and Beth A. Brooke were elected as Class II directors for three-year terms.
- Ernst & Young LLP was ratified as the independent registered public accounting firm for fiscal year ending Dec 31, 2026.
- Stockholders approved advisory compensation for named executive officers.
- Voting quorum reached 83.19% of total voting power.
eHealth, Inc. reported its Q1 2026 financial results and announced the resignation of director Cesar Soriano, effective June 18, 2026. In conjunction with this resignation and a previously disclosed term expiration, the company will reduce its board size from ten to eight members.
📋 Key Facts
- Released Q1 2026 financial results for the period ended March 31, 2026, on May 6, 2026.
- Director Cesar Soriano notified the board of his resignation on May 3, 2026, effective June 18, 2026.
- Soriano's resignation is attributed to his role as CEO of Confie Corporation and not any disagreement with the company.
- The Board of Directors will be reduced from ten to eight members following the 2026 Annual Meeting of Stockholders.
- Director Andrea Brimmer's term is also set to expire at the 2026 Annual Meeting.
On March 26, 2026, Andrea C. Brimmer, a director of eHealth, Inc., notified the company of her intention not to stand for re-election at the 2026 Annual Meeting of Stockholders. Her departure is not due to any disagreement with the company's operations, policies, or practices.
📋 Key Facts
- Director Andrea C. Brimmer notified the company of her intent not to stand for re-election on March 26, 2026.
- The departure will occur upon the expiration of her current term at the 2026 Annual Meeting of Stockholders.
- The company explicitly stated there were no disagreements regarding operations, policies, or practices.
- A press release regarding the board change was issued on March 31, 2026.
eHealth, Inc. announced its financial results for the fourth quarter and full fiscal year ended December 31, 2025. The company also disclosed a change in its principal executive office address from Austin, Texas, to Indianapolis, Indiana.
📋 Key Facts
- Financial results for the three and twelve months ended December 31, 2025, were released on February 25, 2026.
- The company's principal executive office moved to 9190 Priority Way West Dr., Suite 110, Indianapolis, IN 46240.
- Supplemental investor materials and conference call slides were furnished as Exhibit 99.2.
- The filing was made under Item 2.02 (Results of Operations and Financial Condition).
eHealth, Inc. has entered into a new $125 million asset-based revolving credit facility to refinance existing debt and fund general corporate purposes. The filing also includes significant amendments to an investment agreement with H.I.G. Capital, including a penalty dividend rate for breaching liquidity covenants.
🚩 Red Flags
- High leverage/liquidity risk: The company immediately drew the full $125M facility, suggesting immediate need for cash.
- Punitive dividend terms: Breach of liquidity covenants triggers a 2.00% increase in PIK dividends to H.I.G., which could accelerate capital depletion.
- Restrictive covenants: Includes a maximum total leverage ratio (starting at 2.50:1.00) and a minimum LTV/CAC ratio covenant.
📋 Key Facts
- Entered into a new $125 million asset-based revolving credit facility (with potential $50M increase) maturing December 2028.
- The Borrower immediately drew the full $125.0 million to repay the existing Blue Torch Credit Agreement and fund general corporate purposes.
- New financing includes a liquidity covenant requiring at least $45.0 million in unrestricted cash monthly.
- Amended H.I.G. Investment Agreement grants H.I.G. rights regarding a new strategy committee and additional governance protections.
- Certificate of Designations amended to include a 2.00% increase in the paid-in-kind dividend rate for Series A Preferred Stock if liquidity covenants are breached.
eHealth, Inc. has adopted amended and restated bylaws following a periodic review and issued a press release updating its fiscal year 2025 guidance based on strong annual enrollment period performance.
🚩 Red Flags
- None identified in this filing.
📋 Key Facts
- Board of Directors adopted Amended and Restated Bylaws effective December 16, 2025.
- Bylaw changes include shifting meeting notice deadlines from Pacific Time to Eastern Time.
- New procedures established for stockholder director nomination requests (questionnaire delivery within five business days).
- Definition of 'principal competitor' clarified for disclosure purposes.
- Company issued a press release on December 18, 2025, updating guidance for FY2025 due to strong AEP performance.
eHealth, Inc. filed an 8-K to announce its financial results for the three and nine months ended September 30, 2025. The filing serves as a formal announcement of quarterly earnings via press release and investor presentation slides.
📋 Key Facts
- Reporting period: Three and nine months ended September 30, 2025.
- Filing date: November 5, 2025.
- The company issued a press release (Exhibit 99.1) regarding third quarter 2025 results.
- Supplemental investor materials were posted to the company's IR webpage (Exhibit 99.2).
eHealth, Inc. entered into a Third Amendment to its Credit Agreement on October 6, 2025. The amendment primarily serves to extend the maturity date of the existing term loan by approximately eleven months.
🚩 Red Flags
- Maturity extension indicates a need for additional runway, common in companies managing liquidity constraints.
📋 Key Facts
- Amendment No. 3 was executed on October 6, 2025.
- The amendment extends the maturity date from February 27, 2026, to January 29, 2027.
- Blue Torch Finance LLC serves as the administrative and collateral agent for the lenders.
- Other material terms of the Original Credit Agreement remain unchanged.
- The outstanding principal amount of the term loan remains unchanged.
eHealth, Inc. announced a transition in its Board of Directors involving the resignation of Aaron Tolson and the appointment of Todd Arden as his successor, both representing H.I.G. Additionally, the company expanded its board by appointing Derrick Duke.
🚩 Red Flags
- None identified; the filing explicitly states the resignation was not due to a disagreement.
📋 Key Facts
- Aaron Tolson resigned from the Board and all committees effective September 17, 2025; resignation was not due to a disagreement with the Company.
- Todd Arden appointed as Class I director effective September 17, 2025, to fill the vacancy created by Mr. Tolson.
- Derrick Duke appointed as Class I director effective September 18, 2025; Board size increased from nine to ten members.
- Todd Arden received a grant of time-based RSUs valued at $150,000, vesting in three equal annual installments.
- H.I.G. will pay Todd Arden $35,000 per month (less company cash retainer) and a $5,000 per diem under specified circumstances.
eHealth, Inc. filed an 8-K to announce its financial results for the second quarter of 2025 (three and six months ended June 30, 2025). The filing includes a press release and supplemental investor materials.
📋 Key Facts
- Reporting period: Three and six months ended June 30, 2025.
- Filing date: August 6, 2025.
- Exhibits include a press release (99.1) and conference call slides (99.2).
- The company is using its investor relations webpage for Regulation FD compliance.
eHealth, Inc. announced the resignation of CEO Fran Soistman and the appointment of Derrick Duke as his successor. Mr. Duke will officially begin his transition on August 4, 2025, following a period of executive advisory from the outgoing CEO.
🚩 Red Flags
- Succession risk: The CEO transition involves an immediate resignation announcement followed by a multi-month advisory period, which can indicate internal friction or rapid leadership shifts.
- Significant severance liability: The new CEO has highly favorable severance terms, including 24 months of salary and accelerated vesting in the event of a change in control.
📋 Key Facts
- Fran Soistman is resigning as CEO effective September 18, 2025; he will serve as an executive advisor until December 31, 2025.
- Derrick Duke appointed as new CEO, effective upon the resignation of Mr. Soistman.
- Derrick Duke's compensation includes a $700,000 base salary and a $600,000 signing bonus (subject to repayment if terminated for cause or resigning without good reason within one year).
- Equity incentives for the new CEO include 300,000 time-based RSUs and 300,000 performance-based RSUs.
- Severance agreement includes 24 months of base salary plus bonus in the event of a 'Qualifying Termination' (without cause or good reason).
eHealth, Inc. announced an extension of CEO Fran Soistman's tenure due to the ongoing search for a successor. Mr. Soistman will remain CEO until September 30, 2025, and serve as an executive advisor through December 31, 2025.
🚩 Red Flags
- Extended CEO search period indicates potential difficulty in finding a permanent successor.
- Significant cash retention award ($1M) used to ensure leadership stability during transition.
📋 Key Facts
- CEO Fran Soistman's departure is delayed from the end of Q2 2025 to a transition period ending September 30, 2025.
- Mr. Soistman will serve as an executive advisor until December 31, 2025.
- The Board approved a $1.0 million cash retention award for Mr. Soistman, payable in January 2026, contingent on his continued employment through the transition period.
- Stockholders approved an amendment to the 2024 Equity Incentive Plan to increase the share pool by 1,500,000 shares.
- Ernst & Young LLP was ratified as the independent registered public accounting firm for fiscal year 2025.
eHealth, Inc. filed an 8-K to announce its financial results for the first quarter ended March 31, 2025 and provided supplemental investor materials.
📋 Key Facts
- Report date: May 7, 2025
- Reporting period: Three months ended March 31, 2025
- The filing includes a press release (Exhibit 99.1) and conference call slides (Exhibit 99.2)
- Information is furnished under Item 2.02 rather than filed.
eHealth, Inc. filed an 8-K to announce its financial results for the fourth quarter and full fiscal year ended December 31, 2024. The filing includes a press release and supplemental investor materials.
📋 Key Facts
- Report date: February 26, 2025
- Reporting period: Three and twelve months ended December 31, 2024
- The company issued a press release (Exhibit 99.1) regarding Q4 and FY2024 results
- Supplemental investor materials were posted to the company's IR webpage (Exhibit 99.2)
eHealth, Inc. issued a press release regarding preliminary operational results for its Annual Enrollment Period (AEP) and provided updated guidance ranges for the fiscal year ending December 31, 2024.
📋 Key Facts
- Report date: December 17, 2024
- The company reported strong performance during the Annual Enrollment Period (AEP).
- The filing includes updated guidance ranges for the fiscal year ending December 31, 2024.
- Information is furnished under Item 7.01 and not filed for purposes of Section 18.
eHealth, Inc. filed an 8-K to announce its financial results for the third quarter and nine months ended September 30, 2024. The filing includes a press release and supplemental investor presentation materials.
📋 Key Facts
- Reporting period: Three and nine months ended September 30, 2024.
- Filing date: November 6, 2024.
- Included exhibits: Press release (99.1) and conference call slides (99.2).
- The company utilized its investor relations webpage for supplemental material disclosure under Regulation FD.
eHealth, Inc. entered into a Second Amendment to its Credit Agreement with Blue Torch Finance LLC on November 1, 2024. The amendment extends the maturity date of existing loans by one year and provides for a reduction in interest margins.
🚩 Red Flags
- The extension of the maturity date suggests the company needed more time to address its upcoming debt obligation due in early 2025.
- Payment of a 1.50% extension fee on $70M ($1.05M) represents an immediate cash outflow to lenders.
📋 Key Facts
- Maturity date extended from February 28, 2025, to February 27, 2026.
- SOFR loan margin reduced from 7.50% to 7.00%.
- Base rate loan margin reduced from 6.50% to 6.00%.
- Company paid an extension fee of 1.50% on the $70.0 million aggregate principal amount.
- Replaced 'exit fee' with a 1.00% 'applicable premium' for voluntary prepayments, plus a potential make-whole provision if prepaid before March 1, 2025.
eHealth, Inc. has announced a retention incentive program for three key executives following the upcoming departure of CEO Fran Soistman. The plan includes cash and RSU awards designed to ensure leadership continuity during the transition.
🚩 Red Flags
- Impending departure of the Chief Executive Officer (CEO).
- The need for significant cash and equity retention packages suggests potential risk in executive turnover during a leadership transition.
- Uncertainty regarding the exact 'Transition Effective Date' creates ambiguity for short-term planning.
📋 Key Facts
- CEO Fran Soistman is set to cease being CEO (Transition Effective Date not specified, but triggers retention vesting).
- Three executives—John Dolan (CFO), Michelle Barbeau, and Gavin Galimi—are receiving retention incentives.
- Each participant is eligible for a $250,000 Cash Retention Award payable in two installments (6 and 18 months post-CEO departure).
- Each participant is eligible for 31,300 RSU Retention Awards vesting over two years starting December 10, 2024.
- Retention incentives are designed to protect against voluntary resignation for 'good reason' or termination by the company without cause.
eHealth, Inc. announced the appointment of Prama Bhatt to its Board of Directors and relevant committees, effective September 24, 2024. This move expands the Board size from eight to nine members.
📋 Key Facts
- Prama Bhatt appointed as Class II director effective September 24, 2024.
- Ms. Bhatt will serve on the Audit Committee and Government and Regulatory Affairs Committee.
- Board size increased from eight to nine members.
- Compensation includes a grant of time-based restricted stock units (RSUs) valued at $175,000, vesting in three equal annual installments.
- Ms. Bhatt will receive pro rata portions of existing cash retainers ($75,000 for director, $10,000 for Audit Committee, and $5,000 for Government and Regulatory Affairs Committee).
eHealth, Inc. announced that CEO Fran Soistman will retire upon the appointment of a successor, which is expected by or before the end of Q2 2025. The company also released its financial results for the second quarter of 2024.
🚩 Red Flags
- Long-term leadership transition period: The successor may not be appointed for up to another two quarters, creating a prolonged period of management uncertainty.
📋 Key Facts
- CEO Fran Soistman notified the company of his intention to retire.
- Succession plan: A successor is expected to be appointed by or before the end of Q2 2025.
- Transition Plan: Mr. Soistman will remain on the Board of Directors following retirement to support the transition.
- The departure is not due to any disagreement regarding company operations, policies, or practices.
- Company released Q2 2024 financial results (three and six months ended June 30, 2024).
eHealth, Inc. held its 2024 Annual Meeting of Stockholders on June 12, 2024, where shareholders approved several key items including the election of three directors and a new equity incentive plan.
📋 Key Facts
- Stockholders approved the eHealth, Inc. 2024 Equity Incentive Plan (the '2024 Equity Plan').
- Stockholders approved an amendment to the 2020 Employee Stock Purchase Plan (ESPP) to increase the share cap by 500,000 shares to a total of 1,000,000 shares.
- Three Class III directors were elected: Erin L. Russell, Cesar M. Soriano, and Dale B. Wolf.
- The appointment of Ernst & Young LLP as independent registered public accounting firm for fiscal year 2024 was ratified.
- Voting participation was high, with 80.59% of total voting power represented at the meeting.
eHealth, Inc. announced the resignation of its CFO, John Stelben, effective August 30, 2024, and the promotion of current Senior VP/Chief Accounting Officer John Dolan to the CFO role effective August 31, 2024.
🚩 Red Flags
- Planned departure of the CFO creates a leadership transition period.
- The appointment of an internal successor often suggests stability, but any CFO turnover in micro/small-cap environments warrants monitoring for underlying accounting issues (though no disagreement was stated).
📋 Key Facts
- CFO John Stelben is resigning effective August 30, 2024; he will serve as a consultant from Sept 1 to Dec 31, 2024, for $10,000/month.
- John Dolan (current SVP, Chief Accounting Officer) to succeed Stelben as CFO and Principal Financial/Accounting Officer on August 31, 2024.
- Stelben will not receive severance or additional equity vesting upon resignation.
- Dolan's compensation includes a $440,000 base salary and target bonus of 75% of base.
- Dolan to receive 48,750 time-based RSUs (3-year vesting) and 26,250 performance-based RSUs tied to adjusted EBITDA margin goals.
eHealth, Inc. issued an 8-K to announce its financial results for the first quarter ended March 31, 2024 and provided supplemental investor materials.
📋 Key Facts
- Report date: May 7, 2024
- Reporting period: First Quarter ended March 31, 2024
- The filing includes a press release (Exhibit 99.1) and conference call slides (Exhibit 99.2)
- Information is furnished under Item 2.02 and not filed for purposes of Section 18 of the Exchange Act.
eHealth, Inc. filed an 8-K to announce its financial results for the fourth quarter and full fiscal year ended December 31, 2023. The filing includes a press release and supplemental investor presentation materials.
📋 Key Facts
- Reporting period: Fourth quarter and fiscal year ended December 31, 2023.
- Filing date: February 27, 2024.
- The company furnished financial results via press release (Exhibit 99.1) and investor presentation slides (Exhibit 99.2).
- Information is 'furnished' rather than 'filed' under Section 18 of the Exchange Act.
eHealth, Inc. issued a press release announcing preliminary financial results for the fourth quarter and full fiscal year ended December 31, 2023.
📋 Key Facts
- Announcement date: January 26, 2024.
- Reporting period: Fourth quarter and fiscal year ended December 31, 2023.
- The information is furnished under Item 2.02 and is not considered 'filed' for purposes of Section 18 of the Exchange Act.